Hyderabad: ReaGene Innovations Private Limited, a start-up incubated at the University of Hyderabad's the ASPIRE-BioNEST, and INDRAS Private Limited have found that an anti-diabetic drug, Ertugliflozin, can be repurposed to treat COVID-19.The findings indicate that repurposed drug not only binds...